Andreas G.
- Country
- Germany
- Department
- Department of Internal Medicine II, Division of Hepatology
Research Overview
- Phase III Randomized Double‑Blind Placebo‑Controlled Study of Oral Elafibranor 120 mg in Adults with Primary Sclerosing Cholangitis
- Evaluation of Sequential Versus Up-Front Administration of Durvalumab, Tremelimumab, and Bevacizumab in Non-Resectable Hepatocellular Carcinoma
- Efficacy and Safety of NNC0194-0499 and Semaglutide in Non-Alcoholic Steatohepatitis with Fibrosis Stages F2-F4: A Dose-Ranging, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 81 of 233 partner sites.
Specializations
Liver Cancer Research
This investigator specializes in treating hepatocellular carcinoma (HCC), with particular focus on both intermediate-stage disease and post-treatment scenarios. Their research encompasses adjuvant therapy approaches and innovative treatment combinations.
- Intermediate-stage HCC management
- Post-surgical treatment strategies
- Combined therapeutic approaches
The work includes evaluation of immunotherapy combinations and comparison with established treatment methods like transarterial chemoembolization.
Chronic Liver Conditions
The investigator conducts research in chronic liver diseases, with specific expertise in primary sclerosing cholangitis (PSC) and non-alcoholic steatohepatitis (NASH). Their work focuses on novel therapeutic approaches for these challenging conditions.
- PSC progression prevention
- NASH treatment strategies
- Liver fibrosis management
Research includes evaluation of innovative compounds for treating chronic liver conditions and preventing disease progression.
Therapeutic Innovation
The investigator explores combination therapy approaches and novel therapeutic agents in hepatology. Their research includes evaluation of both established and experimental treatments for various liver conditions.
- Novel drug development
- Combination treatment strategies
- Disease progression markers
The work involves assessment of therapeutic effectiveness in preventing liver disease progression and improving patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.